Fred Hutchinson Cancer Center on The Conversation

February 22, 2022

As New Zealand’s Omicron infections rise rapidly, genome surveillance is shifting gears

David Welch, University of Auckland, Waipapa Taumata Rau; James Hadfield, Fred Hutchinson Cancer Center; Jemma Geoghegan, University of Otago; Joep de Ligt, ESR, and Michael Bunce, ESR

Without genome sequencing, we would be blind to new variants of COVID-19. As Omicron surges in New Zealand, the sequencing focus is shifting to learning about what causes severe or long-term disease.

Fred Hutchinson Cancer Center

Links

Displaying 1 article

As New Zealand’s Omicron infections rise rapidly, genome surveillance is shifting gears

Authors